T. Rowe Price Associates »

Tango Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $125k 16k 7.72
2024-06-30 $131k 15k 8.60
2024-03-31 $102k 13k 7.99
2023-12-31 $113k 11k 9.96
2023-09-30 $116k 10k 11.35

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Tango Therapeutics

Trv Gp Iv
EcoR1 Capital
Boxer Capital
Nextech Invest
T. Rowe Price Investment Management
Southpoint Capital Advisors
BlackRock
BlackRock
Vanguard Group
Bain Capital Life Sciences Investors
Citadel Advisors
Siren
State Street Corporation
Deerfield Management Company
Geode Capital Management

View all funds holding Tango Therapeutics